Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ...
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The ...
What Happened? A number of stocks fell in the afternoon session after the April PPI report showed wholesale inflation accelerating to 6% annually, with servi...
GoodRx saw a positive market reaction to its first-quarter results, with management attributing performance to robust growth in its Pharma Direct segment and...
Quarterly filings reveal markedly different revenue trajectories and margin profiles for these two healthcare platforms. What do their latest numbers indicate?
Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a ne...
What Happened? Shares of healthcare tech company GoodRx (NASDAQ:GDRX) jumped 7% in the afternoon session after the company reported first-quarter 2026 financ...
Healthcare tech company GoodRx (NASDAQ:GDRX) reported revenue ahead of Wall Street’s expectations in Q1 CY2026, but sales fell by 4.4% year on year to $194 m...
Healthcare tech company GoodRx (NASDAQ:GDRX) will be announcing earnings results this Wednesday afternoon. Here’s what to look for. GoodRx beat analysts’ rev...
What Happened? Shares of healthcare tech company GoodRx (NASDAQ:GDRX) jumped 9.5% in the afternoon session after it announced it would provide access to Novo...
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how healthcare techno...
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...
GoodRx’s stock price has taken a beating over the past six months, shedding 40.7% of its value and falling to $2.31 per share. This was partly due to its sof...
What Happened? Shares of healthcare tech company GoodRx (NASDAQ:GDRX) jumped 3.6% in the afternoon session after the company announced it now offers access t...
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Those leading the charge have not on...
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The ...
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ...
A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the healthcare industry showing significant job losses.
A number of stocks fell in the afternoon session after a surprisingly hot wholesale inflation report fueled investor concerns about persistent price pressures. The Producer Price Index (PPI), a key measure of inflation at the wholesale level, increased by 0.5% in January, significantly higher than the 0.3% anticipated by economists. More concerning was the core PPI, which excludes volatile food and energy prices, as it surged by 0.8%, far exceeding the expected 0.3% rise. This data suggests that inflation may be more entrenched than previously thought, potentially impacting future interest rate decisions. In response to the news, major market indices, including the S&P 500, Dow Jones, and Nasdaq, all traded sharply lower as investors reassessed the economic outlook.
Healthcare tech company GoodRx (NASDAQ:GDRX) reported Q4 CY2025 results exceeding the market’s revenue expectations, but sales fell by 1.9% year on year to $194.8 million. On the other hand, the company’s full-year revenue guidance of $765 million at the midpoint came in 6.2% below analysts’ estimates. Its non-GAAP profit of $0.09 per share was in line with analysts’ consensus estimates.
